Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Bright Green Corporation

BGXXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$0.00(0.00%)
U.S. Market is Open • 14:37

Bright Green Corporation Fundamental Analysis

Bright Green Corporation (BGXX) shows weak financial fundamentals with a PE ratio of -0.52, profit margin of -32.70%, and ROE of -1.16%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.05

Areas of Concern

ROE-1.16%
Operating Margin-22.15%
Cash Position0.15%
Current Ratio0.04
We analyze BGXX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3187.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3187.8/100

We analyze BGXX's fundamental strength across five key dimensions:

Efficiency Score

Weak

BGXX struggles to generate sufficient returns from assets.

ROA > 10%
-75.43%

Valuation Score

Excellent

BGXX trades at attractive valuation levels.

PE < 25
-0.52
PEG Ratio < 2
-0.05

Growth Score

Weak

BGXX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

BGXX shows balanced financial health with some risks.

Debt/Equity < 1
0.17
Current Ratio > 1
0.04

Profitability Score

Weak

BGXX struggles to sustain strong margins.

ROE > 15%
-116.46%
Net Margin ≥ 15%
-32.70%
Positive Free Cash Flow
No

Key Financial Metrics

Is BGXX Expensive or Cheap?

P/E Ratio

BGXX trades at -0.52 times earnings. This suggests potential undervaluation.

-0.52

PEG Ratio

When adjusting for growth, BGXX's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values Bright Green Corporation at 0.62 times its book value. This may indicate undervaluation.

0.62

EV/EBITDA

Enterprise value stands at -0.66 times EBITDA. This is generally considered low.

-0.66

How Well Does BGXX Make Money?

Net Profit Margin

For every $100 in sales, Bright Green Corporation keeps $-32.70 as profit after all expenses.

-32.70%

Operating Margin

Core operations generate -22.15 in profit for every $100 in revenue, before interest and taxes.

-22.15%

ROE

Management delivers $-1.16 in profit for every $100 of shareholder equity.

-1.16%

ROA

Bright Green Corporation generates $-75.43 in profit for every $100 in assets, demonstrating efficient asset deployment.

-75.43%

Following the Money - Real Cash Generation

Operating Cash Flow

Bright Green Corporation generates limited operating cash flow of $-2.63M, signaling weaker underlying cash strength.

$-2.63M

Free Cash Flow

Bright Green Corporation generates weak or negative free cash flow of $-5.34M, restricting financial flexibility.

$-5.34M

FCF Per Share

Each share generates $-0.03 in free cash annually.

$-0.03

FCF Yield

BGXX converts -68.68% of its market value into free cash.

-68.68%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.52

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.62

vs 25 benchmark

P/S Ratio

Price to sales ratio

18.09

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.17

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.04

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.16

vs 25 benchmark

ROA

Return on assets percentage

-0.75

vs 25 benchmark

ROCE

Return on capital employed

-0.80

vs 25 benchmark

How BGXX Stacks Against Its Sector Peers

MetricBGXX ValueSector AveragePerformance
P/E Ratio-0.5229.43 Better (Cheaper)
ROE-116.46%800.00% Weak
Net Margin-3269.72%-20145.00% (disorted) Weak
Debt/Equity0.170.30 Strong (Low Leverage)
Current Ratio0.044.64 Weak Liquidity
ROA-75.43%-17936.00% (disorted) Weak

BGXX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bright Green Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ